Question 1

Who are the top researchers at Avail Clinical Research?

Accepted Answer

Ranked on the quality score, Daniel Gruener lead among researchers whose main affiliation is Avail Clinical Research.

Question 2

What are the most cited papers from Avail Clinical Research?

Accepted Answer

The most cited paper from Avail Clinical Research is "A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C" (Eric Lawitz, Daniel Gruener, John M. Hill et al., 2012), with 158 citations. Next come "GS‐9857 in patients with chronic hepatitis C virus genotype 1–4 infection: a randomized, double‐blind, dose‐ranging phase 1 study" (65) and "Safety, Pharmacokinetics and Pharmacodynamics of the Oral Toll-Like Receptor 7 Agonist GS-9620 in Treatment-Naive Patients with Chronic Hepatitis C" (31).

Question 3

Which research topics does Avail Clinical Research publish most on?

Accepted Answer

By volume in 2022-now: Diabetes Management and Research, HIV, Drug Use, Sexual Risk and Hyperglycemia and glycemic control in critically ill and hospitalized patients.

Question 4

Which fields of science does Avail Clinical Research work in?

Accepted Answer

In all years, 50% of research at Avail Clinical Research is in Social Sciences, 30% in Health Sciences. Its largest fields are Medicine (22%), Economics, Econometrics and Finance (20%), Social Sciences (17%). It does 1.5× the world's share of Social Sciences.

Question 5

Is Avail Clinical Research's research output growing?

Accepted Answer

Output in 2022-2025 was 100% lower than in 2018-2021.